BiotechTube
Home/Altimmune/Vipin K. Garg, Ph.D.
VK

Vipin K. Garg, Ph.D.

President and Chief Executive Officer

Altimmune

Therapeutic Areas

ObesityMetabolic Dysfunction-Associated Steatohepatitis (MASH)Hypercholesterolemia

Altimmune Pipeline

DrugIndicationPhase
PemvidutideObesityPhase 2
ALT-400Undisclosed Metabolic IndicationPreclinical

Leadership Team at Altimmune

SH
Scott Harris, M.D.
Chief Medical Officer
RE
Richard Eisenstadt
Chief Financial Officer
CM
Cynthia Musante, Ph.D.
Senior Vice President, Research & Development
WS
William Symonds, Pharm.D.
Board Member
JG
John Gill
Board Member
View full Altimmune profile